AEMD -
AETHLON MEDICAL INC
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| 3.55 0.14 (3.94%) |
--- |
--- |
0.02 (0.54%) |
0.0 (0.0%) |
0.11 (3.07%) |
0.0 (0.0%) |
-0.02 (-0.56%) |
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Earnings & Ratios
- Basic EPS:
- -8.58
- Diluted EPS:
- -8.58
- Basic P/E:
- -0.4301
- Diluted P/E:
- -0.4301
- RSI(14) 1m:
- 58.33
- VWAP:
- 3.67
- RVol:
Events
| Period |
Kind |
Movement |
Occurred At |
Related News
Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
Nov 12, 2025 21:15
Correction to Previous Release: “Promeza MG Works with AETH to Support its LS25 Predicación y Migración Conference”
Sep 30, 2025 19:50
Aethlon Medical Announces Pricing of $4.5 Million Public Offering
Sep 04, 2025 13:15
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025
Aug 05, 2025 12:01
Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update
Jun 26, 2025 20:15
Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream
Jun 17, 2025 11:00
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma
May 14, 2025 12:01
Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal
Mar 10, 2025 12:01
Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025
Feb 13, 2025 13:01
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
Feb 05, 2025 13:01